Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market

Lytix Biopharma AS (6BG) Balance Sheet

0 Followers

Lytix Biopharma AS Balance Sheet

Lytix Biopharma AS's total assets for Q4 2022 were kr152.02M, a decrease of -14.30% from the previous quarter. DE:6BG total liabilities were kr16.89M for the fiscal quarter, a 25.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19
Total Assets
kr 152.02Mkr 202.96Mkr 32.62Mkr 17.43M
Total Liabilities
kr 16.89Mkr 13.34Mkr 12.73Mkr 3.85M
Total Equity Gross Minority
kr 135.13Mkr 189.62Mkr 19.89Mkr 13.58M
Total Capitalization
kr 135.13Mkr 189.62Mkr 19.89Mkr 13.58M
Preferred Stock Equity
----
Capital Lease Obligations
----
Currency in NOK

Lytix Biopharma AS Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis